Nasdaq · Healthcare
Sotera Health Co (SHC)
As-reported financials and recent SEC filings for Sotera Health Co, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.16B
Net income
$77.9M
Net margin
6.7%
Diluted EPS
$0.27
ROE
12.9%
P/E (TTM)
42.4×
Market cap
$4.96B
Debt / equity
3.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.5M |
| Gross profit | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M |
| Operating income | — | $297.6M | $276.7M | $248.3M | $256.7M |
| Net income | $77.9M | $44.4M | $51.4M | $-233.6M | $116.9M |
| Diluted EPS | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-29
View on EDGAR →42026-05-27
View on EDGAR →42026-05-27
View on EDGAR →32026-05-27
View on EDGAR →42026-05-27
View on EDGAR →42026-05-27
View on EDGAR →42026-05-27
View on EDGAR →42026-05-27
View on EDGAR →Go deeper on SHC
Search Sotera Health Co’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.